1. 1 Babiker, A., Andersson, O., Lund, E., Xiu, R. J., Deeb, S., Reshef, A., Leitersdorf, E., Diczfalusy, U. and Björkhem, I. (1997) Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 272; 26253–26261.
2. 2 Bancroft, J. D., Cook, H. C. and Stirling, R. W. (1994) Manual of Histological Techniques and Their Diagnostic Application, 4th ed., New York.
3. 3 Banerjee, A., Kocarek, T. A. and Novak, R. F. (2000) Identification of a ubiquitination-target/substrate-interaction domain of cytochrome P-450 (GYP) 2E1. Drug Metab. Dispos. 28; 118–124.
4. 4 Bastona, E. and Leroux, F. R. (2007) Inhibitors of steroidal cytochrome P450 enzymes as targets for drug development. Recent Pat. Anticancer Drug Discov. 2; 31–58.
5. 5 Bhat, M., Kalam, R., Qadri, S. S., Madabushi, S. and Ismail, A. (2013) Vitamin D deficiency induced muscle wasting occurs through the ubiquitin proteasome pathway and is partially corrected by calcium in male rats. Endocrinology 154; 4018–4029.